These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3182415

  • 1. Time course of the antibacterial activity of erythromycin stearate and erythromycin acistrate against two Staphylococcus aureus strains in vitro.
    Korkeala H, Männistö PT.
    J Antimicrob Chemother; 1988 Aug; 22(2):127-33. PubMed ID: 3182415
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
    Männistö PT, Hanhijärvi H, Havas A, Vuorela A, Komulainen H, Rauramaa V.
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1028-33. PubMed ID: 2778707
    [Abstract] [Full Text] [Related]

  • 3. Comparative liver toxicity of various erythromycin derivatives in animals.
    Viluksela M, Hanhijärvi H, Husband RF, Kosma VM, Collan Y, Männistö PT.
    J Antimicrob Chemother; 1988 Jun; 21 Suppl D():9-27. PubMed ID: 3391880
    [Abstract] [Full Text] [Related]

  • 4. Penetration of erythromycin into periapical lesions after repeated doses of erythromycin acistrate and erythromycin stearate: a pilot study.
    Tuominen RK, Lehtinen R, Peltola J, Wikberg R, Gordin A, Kokkonen P, Pohto P.
    Oral Surg Oral Med Oral Pathol; 1991 Jun; 71(6):684-8. PubMed ID: 2062521
    [Abstract] [Full Text] [Related]

  • 5. Erythromycin acistrate and erythromycin stearate in the treatment of non-gonococcal urethritis.
    Rostila T, Visa K, Gordin A, Antikainen R.
    J Antimicrob Chemother; 1988 Jun; 21 Suppl D():113-9. PubMed ID: 3391873
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sub-inhibitory and post-antibiotic effects of spiramycin and erythromycin on Staphylococcus aureus.
    Webster C, Ghazanfar K, Slack R.
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():33-9. PubMed ID: 3182445
    [Abstract] [Full Text] [Related]

  • 9. Effect of erythromycin on the oro-caecal transit time in man.
    Lehtola J, Jauhonen P, Kesäniemi A, Wikberg R, Gordin A.
    Eur J Clin Pharmacol; 1990 Jul; 39(6):555-8. PubMed ID: 2095341
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of erythromycin acistrate and erythromycin stearate on human colonic microflora.
    Kaukoranta-Tolvanen SS, Renkonen OV, Gordin A, Tamm L, Männistö PT.
    Scand J Infect Dis; 1989 Jul; 21(6):717-20. PubMed ID: 2617212
    [Abstract] [Full Text] [Related]

  • 12. Fate of single oral doses of erythromycin acistrate, erythromycin stearate and pelleted erythromycin base analysed by mass-spectrometry in plasma of healthy human volunteers.
    Männistö PT, Taskinen J, Ottoila P, Solkinen A, Vuorela A, Nykänen S.
    J Antimicrob Chemother; 1988 Jun; 21 Suppl D():33-43. PubMed ID: 3391874
    [Abstract] [Full Text] [Related]

  • 13. Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives.
    Pestka S, Vince R, LeMahieu R, Weiss F, Fern L, Unowsky J.
    Antimicrob Agents Chemother; 1976 Jan; 9(1):128-30. PubMed ID: 1259386
    [Abstract] [Full Text] [Related]

  • 14. Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres.
    Reeves DS, Holt HA, Phillips I, King A, Miles RS, Paton R, Wise R, Andrews JM.
    J Antimicrob Chemother; 1991 Apr; 27(4):469-74. PubMed ID: 1856126
    [Abstract] [Full Text] [Related]

  • 15. Erythromycin and 2'-acetyl erythromycin concentrations in plasma and pelvic tissues after repeated doses of erythromycin acistrate.
    Lehtonen L, Wikberg R, Karhunen M, Kokkonen P, Tuominen R.
    Arzneimittelforschung; 1993 Jan; 43(1):53-6. PubMed ID: 8447849
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci.
    Hamilton-Miller JM.
    J Antimicrob Chemother; 1992 Feb; 29(2):141-7. PubMed ID: 1506329
    [Abstract] [Full Text] [Related]

  • 19. [Synthesis and antibacterial activity of 3-hydroxy-6-O-methylerythromycin-9-O-substituted oxime derivatives].
    Chen SX, Xu XD, Yu LX.
    Yao Xue Xue Bao; 2001 Aug; 36(8):581-4. PubMed ID: 12579933
    [Abstract] [Full Text] [Related]

  • 20. Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome.
    Paulsen P, Simon C, Peters O, Hedderich J, Heim P.
    Chemotherapy; 1992 Aug; 38(3):185-90. PubMed ID: 1324831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.